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S U M M A R Y
Objectives: The aim of this study was to characterize carbapenem-resistant Klebsiella pneumoniae (CRKP)
isolates recovered from clinical specimens at a tertiary care hospital in Egypt over a period of 15 months.
Methods: Eight CRKP isolates were included in this study. The minimum inhibitory concentrations of
different antibiotics were determined by broth microdilution and Etest methods. Multilocus sequence
typing was performed. Antibiotic resistance genes were assessed by PCR and DNA sequencing. Plasmid
analysis was done by S1 nuclease digestion of whole genomic DNA followed by pulsed-ﬁeld gel
electrophoresis (S1-PFGE).
Result: Eight carbapenem-resistant NDM-1-producing K. pneumoniae isolates of three different
sequence types (ST) were identiﬁed (ST147, ST11, and ST17), in which blaNDM-1 was carried by either
IncR or untypeable plasmids. Seven out of the eight isolates also contained the rmtF methylase gene.
Conclusion: This study describes the occurrence of IncR plasmids carrying blaNDM-1 and rmtF in Egypt,
raising concerns regarding this type of replicon and its role in the transmission of these resistance
determinants.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idNew Delhi metallo-b-lactamase (NDM)-producing Klebsiella
pneumoniae isolates have spread globally, causing infections with a
signiﬁcant and high mortality rate.1 Over a period of 15 months,
from September 2013 to December 2014, a total of 157 Klebsiella
spp isolates were recovered from different clinical specimens
processed at the microbiology laboratory of Theodor Bilharz
Research Institute (TBRI), a tertiary care hospital in Egypt. Thirteen
of them were found to be resistant to imipenem or meropenem by
disk diffusion and Vitek2 system (bioMe´rieux, Marcy L’Etoile,
France). Eight of these isolates were available for this study.
Minimum inhibitory concentrations (MICs) of a set of
antibiotics were determined by standardized broth microdilution
method following the guidelines of the Clinical and Laboratory
Standards Institute (CLSI).2 Those of ertapenem and meropenem
were also performed by Etest strip method (bioMe´rieux, Marcy* Corresponding author.
E-mail address: doaagamal@gmail.com (D. Gamal).
1 Doaa Gamal and Marta Ferna´ndez-Martı´nez contributed equally to this article.
http://dx.doi.org/10.1016/j.ijid.2015.12.003
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).L’Etoile, France) (Table 1). Data were interpreted according to the
European Committee on Antimicrobial Susceptibility Testing
(EUCAST) breakpoints,3 except for nalidixic acid, which was
categorized according to CLSI standards.2 One isolate (K4) was
susceptible to gentamicin, ciproﬂoxacin, and nalidixic acid
(Table 1). The remaining seven isolates were resistant to
cephalosporins, carbapenems, quinolones, and aminoglycosides.
All isolates retained susceptibility to both colistin and tigecycline.
Discrepancies between the broth microdilution and Etest results
were noted regarding carbapenems (Table 1). Such discordance
between the two methods has been reported previously in VIM-1-
producing K. pneumoniae.4
PCR was performed, followed by sequencing for the genes
coding for extended-spectrum b-lactamases (blaSHV, blaTEM, blaCTX-
M), plasmid-mediated AmpC b-lactamases, carbapenemases
(blaKPC, blaIMP, blaVIM, blaNDM, blaOXA-48), plasmid-mediated quino-
lone resistance (qnrA, qnrB, qnrS), aminoglycoside-modifying
enzymes (aac(3)-Ia, aac(3)-IIa, aac(3)-IVa, aac(60)-Ib ant(200)-Ia,
aph(30)-Ia, aph(30)-IIa, aph-(30)-VIa), and methyltransferases
(npmA, armA, rmtB, rmtC, and rmtF).5–8ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Mechanisms of resistance to selected antimicrobial agents in Klebsiella pneumoniae isolates and derived transformants and transconjugants
PFGE/ST Isolate MIC (mg/ml) Plasmid
replicon
Resistance determinants
CAZ CTX IMP MEM MEM (Etest) ERT (Etest) AK GEN TOB CIP NAL SXT TIG COL
A/147 K1 >128 >128 >128 >128 >32 >32 >128 >128 >128 >128 >128 >128 2 0.125 colE, R NDM-1, CTX-M-15, SHV-11,
aac(3)-IIa, aph(30)-Ia,
aac(60)-Ib-cr, rmtF, qnrB
TF K1 >128 >128 4 8 1 1 16 64 32 0.125 4 >128 0.06 0.06 R NDM-1, CTX-M-15, aac(3)-IIa,
aph(30)-Ia, aac(60)-Ib-cr, qnrB
K6 >128 >128 16 128 2 6a >128 >128 >128 >128 >128 >128 2 0.25 colE, R NDM-1, CTX-M-15, SHV-11,
aac(3)-IIa, aph(30)-Ia,
aac(60)-Ib-cr, rmtF, qnrB
K7 >128 >128 16 16 2 6a >128 >128 >128 >128 >128 >128 1 0.06 colE, R NDM-1, CTX-M-15, SHV-11,
aac(3)-IIa, aph(30)-Ia, aac(60)-
Ib-cr, rmtF, qnrB
K9 >128 >128 16 32 2 6 >128 >128 >128 >128 >128 >128 1 0.125 colE, R NDM-1, CTX-M-15, SHV-11,
aac(3)-IIa, aph(30)-Ia,
aac(60)-Ib-cr, rmtF, qnrB
TF K9 >128 >128 4 8 1 1.5a 8 64 32 0.25 4 >128 0.06 0.125 R NDM-1, CTX-M-15, aac(3)-IIa,
aph(30)-Ia, aac(60)-Ib-cr, qnrB
K10 >128 >128 >128 >128 >32 >32 >128 >128 >128 >128 >128 >128 2 0.125 colE, R NDM-1, CTX-M-15, SHV-11,
aac(3)-IIa, aph(30)-Ia,
aac(60)-Ib-cr, rmtF, qnrB
B/17 K4 >128 >128 4 8 2 2 128 0.5 8 0.5 8 >128 0.5 0.125 colE, R, L/M NDM-1, CTX-M-14, SHV-11,
SHV-12, TEM-1, aph(30)VIa, qnrS
TF K4 >128 >128 4 8 1 0.75a 8 0.5 4 0.125 4 >128 0.06 0.06 R NDM-1, SHV-12, aph(30) VIa, qnrS
TC K4 8 >128 0.06 0.06 0.023 0.06 128 1 1 0.06 2 32 0.06 0.06 L/M CTX-M-14, aph(30)VIa
C/11 K5 >128 >128 128 >128 >32 >32 >128 >128 >128 >128 >128 >128 0.25 0.25 colE, R, repF NDM-1, CTX-M-15, SHV-11,
aph(30)-Ia, aac(60)-Ib, rmtF, qnrB
TF K5 >128 >128 4 4 0.75 1 >128 >128 >128 0.06 2 16 0.06 0.06 Untypeable NDM-1, aac(60)-Ib, rmtF, qnrB
K11 >128 >128 4 64 4a >32 >128 >128 >128 128 >128 >128 1 0.125 colE, R, repF NDM-1, CTX-M-15, SHV-11,
aph(30)-Ia, aac(60)-Ib, rmtF, qnrB
TC K11 >128 >128 8 8 0.5a 0.75a >128 >128 >128 0.125 8 >128 0.06 0.06 Untypeable NDM-1, aac(60)-Ib, rmtF, qnrB
E. coli Top10 0.25 0.06 0.25 0.06 0.016 0.002 2 0.5 0.5 0.06 2 4 0.125 0.06 NA NA
E. coli J53 0.5 0.06 0.25 0.06 0.012 0.002 4 2 1 0.06 8 >128 0.06 0.06 NA NA
PFGE, pulsed-ﬁeld gel electrophoresis; ST, sequence type; MIC, minimum inhibitory concentration; CAZ, ceftazidime; CTX, cefotaxime; IMP, imipenem; MEM, meropenem; ERT, ertapenem; AK, amikacin; GN, gentamicin; TOB,
tobramycin; CIP, ciproﬂoxacin; NAL, nalidixic acid; SXT, trimethoprim–sulfamethoxazole; TIG, tigecycline; COL, colistin; TF, transformed cell; TC, transconjugant; NA, not applicable.
a Indicates the presence of microcolonies that increase in size and number over time.
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D. Gamal et al. / International Journal of Infectious Diseases 43 (2016) 17–20 19Clonal relatedness of the isolates was assessed by pulsed-ﬁeld
gel electrophoresis (PFGE) and multilocus sequence typing
(MLST) (http://www.pasteur.fr/recherche/genopole/PF8/mlst/
Kpneumoniae.html). MLST classiﬁed the isolates into three
sequence type (ST) clones: ST147 (n = 5 isolates), ST11 (n = 2),
and ST17 (n = 1), which coincided with the same PFGE proﬁles.
The three ST clones were positive for blaNDM-1 and blaSHV-11.
blaCTX-M-15, qnrB, aph(30)-I, aac(60)-Ib (the variant –cr was also
found in ST147), and rmtF were also present in all strains except for
the ST17 K. pneumoniae isolate, which had blaSHV-12, blaCTX-M-14,
blaTEM-1, qnrS, and aph(3
0)-VI (Table 1).
The ﬁrst isolation of NDM-1 in Egypt was reported in 2013 from
one ST11 K. pneumoniae isolate that was recovered from a
hospitalized patient in an intensive care unit of a cancer hospital
in Cairo.9 Moreover blaNDM-1 has been described in two Pseudo-
monas aeruginosa isolates,10 and more recently in 59/150
Acinetobacter baumannii isolates,11 thus revealing the spread of
blaNDM-1 beyond Enterobacteriaceae and conﬁrming the ability of
this gene to spread over several plasmids of variable host ranges.12
PCR-based plasmid replicon typing was done as described
previously.5 All isolates were positive for colE-like and IncR. In
addition, ST11 isolates were also positive for repF and the ST17
isolate was positive for IncL/M (Table 1).
The genetic environment of blaNDM-1 was assessed by PCR
mapping as described previously.12 In all but one isolate the same
gene arrangement (DISAba125_ blaNDM-1_bleMBL), identical to that
of the plasmid pCR7-E-NDM-1 from strain Escherichia coli CR7
(GenBank accession number KP826713), was observed. On the
other hand, the isolate of ST17 presented the cassette arrangement
(DISAba125_IS630_DISAba125_blaNDM-1_bleMBL), similar to that of
the plasmid pTR1 from strain K. pneumoniae 1301 (GenBank
accession number KJ187751).
Trials for conjugation experiments were done using the
blaNDM-1 producers as the donors and azide-resistant E. coli J53
as the recipient strain. Transconjugants were selected at two
different temperatures (30 and 37 8C) using selective MacConkey
agar plates with azide (200 mg/ml) and different antibiotics at
different concentrations: imipenem (4 mg/ml) or meropenem
(0.5 mg/ml) or ceftazidime (4 mg/ml) or cefotaxime (4 mg/ml) or
cefoxitin (10 mg/ml). However they were only successful for ST11
isolates, in which the plasmid was untypeable, and for the ST17
isolate, which gave a blaCTX-M-14-positive transconjugant but
blaNDM-1-negative. Plasmid DNA extraction was done by alkaline
lysis method using a Qiagen Midi Kit (Qiagen, Hilden, Germany)
following the manufacturer’s protocol. Electrotransformation
experiments into E. coli Top10 were performed using represen-
tative parental strains from each ST-type. Transformants were
selected on brain–heart infusion agar with meropenem 0.5 mg/
ml. The resistance phenotype and gene content of transconju-
gants and transformants were assessed by broth microdilution
and PCR, respectively, and compared to those of parental cells
(Table 1).
Plasmid analysis by S1 nuclease digestion of whole genomic
DNA followed by PFGE (S1-PFGE) and hybridization with DIG-
labelled probes for blaNDM-1, blaCTX-M-14, blaCTX-M-15, rmtF, and
IncR (data not shown), showed that isolates of different clones had
multiple plasmids of varying sizes. In the ST147 isolates, the
blaNDM-1 together with blaCTX-M-15 were found on IncR plasmids
ranging from approximately 60 to 97 kb, whereas rmtF was
carried on another plasmid of about 100 kb. In the ST17 isolate,
blaNDM-1 was carried on an IncR plasmid of approximately
145.5 kb, while blaCTX-M14 was found on a plasmid of about
55 kb. The two ST11 isolates had a similar size IncR plasmid
(approximately 48 kb) carrying blaCTX-M15, whereas the blaNDM-1
and rmtF genes were contained in an untypeable plasmid of
around 170 kb.rmtF in association with blaNDM-1 has been reported recently
from various parts of the world.13 Its co-existence in the isolates
presented here is the ﬁrst description from Egypt. This demands
further investigation and raises the alarm regarding its possible
endemicity in the region.
IncR plasmids carrying multiple resistance genes have been
reported increasingly in Enterobacteriaceae isolates.14,15 Although
these plasmids are known to be non-transferable and non-
mobilizable, their role in the transmission of resistance has been
attributed to transposition events or plasmid recombination
leading to multi-replicons, contributing to the high plasticity
observed in bacterial plasmids.14
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